期刊文献+

肝素酶介导的肝癌细胞与血管内皮细胞黏附及穿内皮迁移

Heparanase-mediated adhesion with vascular endothelial cell and trans-endothelial migration of hepatocellular carcinoma cells
下载PDF
导出
摘要 目的:探讨肝素酶(heparanase,HPSE)对肝细胞癌(hepatocellular carcinoma,HCC)细胞与血管内皮细胞黏附及穿内皮迁移的影响。方法:选用人正常脐静脉内皮细胞株HUVEC-C,肝LO-2细胞,肝癌Hep G2、BEL-7402和HCCLM3细胞,用Real-time PCR筛选高表达HPSE的HCC细胞;设计4个HPSE基因RNA干扰(RNA interference,RNAi)序列、构建质粒,并筛选出最优RNAi质粒;用该RNAi质粒转染高表达HPSE的HCC细胞,同时设空白对照组、阴性对照组和未转染的HCC细胞组;黏附试验观察各组HCC细胞与HUVEC-C细胞的黏附情况;Transwell小室法观察HCC细胞穿HUVEC-C细胞迁移情况;癌细胞均以0.25%玫瑰红染色、光镜下观察;酶标仪法分别测定脱色后各组细胞D值并分析比较。结果:HCCLM3细胞HPSE mRNA表达水平显著高于肝LO-2、Hep G-2和Bel-7402细胞[(5.72±0.62)vs(1.05±0.09)、(2.65±0.31)和(3.43±0.58),均P<0.01)];设计的4个HPSE之RNAi载体,以si HPSE-3158对HPSE基因表达的抑制效果最佳(P<0.05)。RNAi组HCCLM3细胞与HUVEC-C细胞黏附率显著低于空白对照组、阴性对照组和未转染的HCCLM3细胞组[(0.31±0.04)vs(0.46±0.06)、(0.45±0.05)和(0.64±0.09),均P<0.01)]。RNAi组HCCLM3细胞穿HUVEC-C细胞迁移率也显著低于空白对照组、阴性对照组和未转染的HCCLM3细胞组[(0.28±0.03)vs(0.41±0.04)、(0.41±0.05)和(0.43±0.05),均P<0.05)]。结论:HPSE参与介导HCC细胞与血管内皮细胞的黏附及HCC细胞穿内皮迁移,可能是HCC微血管捕获、血行转移的重要因素。 Objective:To explore the effect of heparanase (HPSE) on adhesion with vascular endothelial cell and trans-endothelial migration of hepatocellular carcinoma (HCC) cells. Methods:Human normal umbilical vein endothelial cell HUVEC-C line , hepatic LO-2 cells, and hepatic carcinoma HepG2, BEL-7402 and HCCLM3 cells were selected to use. HCC cells with high expression of HPSE were screened using Real-time PCR. Four RNA interference (RNAi) sequences of HPSE gene were designed, and the corresponding plasmids were constructed respectively, and the RNAi plasmids with the highest efficiency were screened out, which were transfected into HCC cells with high expression of HPSE. At the same time, blank control (BC) group, negative control (NC) group and untransfected HCC cell group were set up. Adhesion test was used to detect adhesion situation of HCC cell and HUVEC-C cell in each group and Transwell assay was performed to determine the trans-HUVEC-C cell migration of HCC cells. The HCC cells were stained with 0.25% Rose Bengal and observed under inverted microscope. After decolorization, D values of the HCC cells in each group were determined and compared using an enzyme-labeled instrument. Results: Expression level of HPSE mRNA in the HCCLM3 cells was significantly higher than those in hepatic LO-2, HepG-2 and Bel-7402 cells ([5.72±0.62] vs [1.05±009], [2.65±0.31] and [3.43±0.58], all P〈0.01 ). Of the designed 4 RNAi plasmids of HPSE, siHPSE-3158 plasmid showed the best inhibitory effect on expression of HPSE gene (P〈0.05). The adhesion rate of HCCLM3 cells and HUVEC-C cells in RNAi group was significantly lower than those in BC, NC and untransfected HCCLM3 cell groups ([031±0.04] vs [0.46±0.06], [0.45±0.05] and [0.64±0.09], all P〈0.01). The trans-HUVEC-C cell migration rate of HCCLM3 cell in RNAi group was also significantly lower than those in BC, NC and untransfected HCCLM3 cell group ([0.284±0.029] vs [0.41±0.04], [0.41±0.05] and [0.43±0.05], all P〈0.05). Conclusion: HPSE might be involved in mediating the adhesion of HCC cells and vascular endothelial cells as well as trans-endothelial cells migration, which could be a key factor in the adhesion to vascular endothelial cells and hematogenous metastasis of HCC cells.
作者 陈晓鹏 江雯 张文君 崔巍 CHEN Xiaopeng JIANG Wen ZHANG Wenjun CUI Wei(Department of Hepatobiliary Surgery, Yijishan Hospital Affiliated to Wannan Medical College, Wuhu 241001, Anhui, China)
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2016年第5期656-662,共7页 Chinese Journal of Cancer Biotherapy
基金 国家自然科学基金资助项目(No.81272412)~~
关键词 肝素酶 肝细胞癌 血管内皮细胞 微血管捕获 黏附 迁移 heparanase hepatocellular carcinoma vascular endothelial cell capillary capture adhesion migrtion
  • 相关文献

参考文献23

  • 1沈建宇,甘绍举,胡黎黎,赵明,谢浩,丁先锋.生物标记物在肝细胞肝癌诊断中的应用[J].医学分子生物学杂志,2015,12(1):50-53. 被引量:6
  • 2王健,孙燕,崔云龙,郑红,李强.肝癌多中心发生与肝内转移的临床病理学差异研究[J].中华肝胆外科杂志,2009,15(4):247-250. 被引量:12
  • 3樊嘉,史颖弘.肝癌复发和转移的新理念[J].中华消化外科杂志,2010,9(1):10-11. 被引量:25
  • 4TAKIZAWA D,KAKIZAKI S,SOHARA N,et al.Hepatocellular carcinoma with portal vein tumor thrombosis:clinical characteristics,prognosis,and patient survival analysis[J/OL].Dig Dis Sci,2007,52(11):3290-3295[2016-07-04].http://link.springer.com/article/10.1007%2 Fs10620-007-9808-2.
  • 5HAN K,KIM J H,KO G Y,et al.Treatment of hepatocellular carcinoma with portal venous tumor thrombosis:a comprehensive review[J/OL].World J Gastroenterol,2016,22(1):407-416[2016-07-04].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698503/.
  • 6VLODAVSKY I,FRIEDMANN Y,ELKIM M,et al.Mammalian heparanase:gene cloning,expression and function in tumor progression and metastasis[J/OL].Nat Med,1999,5(7):793-802[2016-07-04].http://www.nature.com/nm/journal/v5/n7/full/nm0799_793.html.
  • 7CHEN G,DANG Y W,LUO D Z,et al.Expression of heparanase in hepatocellular carcinoma has prognostic significance:a tissue microarray study[J/OL].Oncol Res,2008,17(4):183-189[2016-07-04].http://www.ingentaconnect.com/content/cog/or/2008/00000017/00000004/art00005?token=004e18641b 39d 6647e442f20672136766a256a4979457c7a6a687627502b333e3568263 c2b6db0.
  • 8CHEN X P,LIU Y B,RUI J,et al.Heparanase mRNA expression and point mutation in hepatocellular carcinoma[J/OL].World J Gastroenterol,2004,10(19):2795-2799[2016-07-04].http://www.wjgnet.com/1007-9327/full/v10/i19/2795.htm.
  • 9WANG Q,SHEN Y,WANG P,et al.The expression of heparanase mRNA and its clinical significance in hepatocellular carcinoma[J/OL].J Cancer Res Ther,2013,9(2):250-252[2016-07-04].http://www.cancerjournal.net/article.asp?issn=0973-1482;year=2013;volume=9;issue=2;spage=250;epage=252;aulast=Wang.
  • 10ZHENG L D,JIANG G S,MEI H,et al.Small RNA interference-mediated gene silencing of heparanase abolishes the invasion,metastasis and angiogenesis of gastric cancer cells[J/OL].BMC Cancer,2010,10:33-33[2016-07-04].http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834619/.

二级参考文献23

  • 1Feng Li,Benjamin Tiede,Joan Massague,Yibin Kang.Beyond tumorigenesis: cancer stem cells in metastasis[J].Cell Research,2007,17(1):3-14. 被引量:86
  • 2李强,刘宁,李慧,任秀宝,马维东,张毓青,郝希山.荧光定量PCR法扩增MAGE-1、MAGE-3及AFP基因联合检测肝癌病人外周血微小转移[J].中华肝胆外科杂志,2007,13(1):13-17. 被引量:3
  • 3汤钊猷.转移复发-肝癌研究的重中之重[J].中华消化外科杂志,2007,6(1):2-2. 被引量:12
  • 4Li Q, Li HK, Butt K, et al. Factors associated with disease survival after surgical resection in Chinese patients with hepatocellular carcinoma. World J Surg, 2006, 30: 439-445.
  • 5Paradis V, Laurendeau I, Vidaud M, et al. Clonal analysis of macronodules in cirrhosis. Hepatology, 1998, 28:953-958.
  • 6Shimada M, Hamatsu T, Yamashita Y, et al. Characteristics of multicentric hepatocellular carcinomas: comparison with intrahepatic metastasis. World J Surg, 2001, 25: 991-995.
  • 7Ueno S, Aoki D, Maeda T, et al. Preoperative assessment of muhicentric occurrence in synchronous small and multiple hepatocellular carcinoma based on image-patterns and histological grading of non-cancerous region. Hepatol Res, 2004, 29: 24- 30.
  • 8Ikeda K, Arase Y, Kobayashi M, et al. Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis. J Gastroenterol, 2003, 38: 865- 876.
  • 9Lee SG, Hwang S, Jung JP, et al. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg, 2007, 94:320-326.
  • 10Bruix J, Sherman M, Llovet JM, et aI. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASLconference. J Hepatol, 2001, 35: 421-430.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部